November 16, 2021 01:45 PM EST
Pharma
Marketing

Mar­ket­ingRx roundup: Bris­tol My­ers taps young NBA play­er to raise heart con­di­tion aware­ness; Pfiz­er, J&J top in­no­va­tion list

Beth Snyder Bulik

Senior Editor

Bris­tol My­ers Squibb is look­ing to shine a light on the rarely di­ag­nosed heart con­di­tion hy­per­trophic car­diomy­opa­thy (HCM) as it awaits an FDA de­ci­sion on …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Ca­griSe­ma’s weight loss da­ta dis­ap­point­ed. What does No­vo do next?

Ex­clu­sive: Flori­da can­cer biotech rais­es $100M Se­ries A

CMS ex­plains what went in­to its first round of drug price ne­go­ti­a­tions

FDA ap­proves Lil­ly's Zep­bound for sleep ap­nea, like­ly crack­ing open Medicare mar­ket

In­side Iso­mor­phic Labs: Demis Has­s­abis’ lab-free vi­sion for biotech’s AI fu­ture

A service from the Financial Times